PMID: 9437404Jan 23, 1998Paper

New principles for the treatment of diffuse pulmonary emphysema

Journal of Internal Medicine
G Hillerdal

Abstract

Emphysema is due to destruction of lung tissue but the main cause of the dyspnoea is a diminished elasticity of the lungs. Medical therapy, such as bronchodilation, corticosteroids, and treatment of intercurrent infections, can give temporary relief. Long-term oxygen treatment can improve and prolong life in patients with severe epmphysema. Lung transplantation is a final option in selected patients. Rehabilitation including exercise training will cause increase in maximal exercise tolerance and decrease of dyspnoea, and thereby an improvement of quality of life. In recent years surgical reduction of the lung volume has been reintroduced and in selected cases given dramatic results. The goal is to reduce the volume in both lungs with about 30%. Depending on the distribution of the emphysema, pieces of the upper or lower lobes will be removed. Sternotomy or bilateral thoracoscopy, using staplers, are the most common methods. Short-term results are good, with an improvement of FEV1 of 22-96%, improved arterial oxygen pressure, and a radical improvement of life quality. The impact on the daily life of the patient can be dramatic. The long-term results are still not well known, and many questions remain before volume reduction surg...Continue Reading

References

Dec 1, 1969·The American Journal of Medicine·S F BoushyR Kohen
Oct 1, 1995·The Annals of Thoracic Surgery·A Wakabayashi
May 1, 1995·Thorax·N P BriffaF C Wells
Sep 1, 1995·Annals of Surgery·A G LittleT C Barcia
Jun 1, 1995·The Annals of Thoracic Surgery·M ZenatiB P Griffith
Jan 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·J D CooperC L Roper
Nov 1, 1994·The Annals of Thoracic Surgery·J D Whitlark, H K Hsu
Feb 1, 1995·American Journal of Respiratory and Critical Care Medicine·N Seersholm, A Kok-Jensen
Feb 1, 1995·Chest·J O Benditt, R K Albert
Mar 1, 1995·American Journal of Respiratory and Critical Care Medicine·A F CheriyanJ M Walsh
Nov 19, 1994·Lancet·R S GoldsteinG H Guyatt
Nov 1, 1994·AJR. American Journal of Roentgenology·W M Thurlbeck, N L Müller
Jun 1, 1994·The Annals of Thoracic Surgery·C G McGregorJ C McDougall
Sep 23, 1993·The New England Journal of Medicine·R Matz
Sep 1, 1993·The Annals of Thoracic Surgery·A Wakabayashi
Jan 1, 1993·Anesthesiology·S J BarkerP Roessler
Apr 8, 1993·The New England Journal of Medicine·G T Ferguson, R M Cherniack
Feb 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·V W Rusch
Feb 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·H A GaissertG A Patterson
Feb 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·R J KeenanC M Bowers
Feb 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·R J McKennaM J Schein
Apr 25, 1996·The New England Journal of Medicine·F C SciurbaR J Landreneau
Apr 1, 1996·The Annals of Thoracic Surgery·R J McKennaA F Gelb
May 1, 1996·The Annals of Thoracic Surgery·J I MillerK A Mansour
Apr 5, 1996·Deutsche medizinische Wochenschrift·S DemertzisH G Borst
Jul 1, 1996·Chest·M BrennerS S Lefrak
Aug 1, 1996·The Annals of Thoracic Surgery·T J KroshusV R Kshettry
Aug 1, 1996·The Annals of Thoracic Surgery·K S Naunheim, M K Ferguson
Oct 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·R BingisserW Weder
Oct 1, 1996·Chest·R K AlbertJ O Benditt
Sep 1, 1996·The European Respiratory Journal·H TeschlerN Konietzko
Feb 1, 1996·AORN Journal·P R GralingP D Kiernan
Nov 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·J D CooperS S Lefrak

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.